Medication lookupLive dataset · 2026-03-09-harness-v3
241 results
Select a medication to view class, mechanism, dosing, monitoring, and pearls.

Interaction flags

Results use the local DDInter dataset and are not medical advice. Confirm against patient-specific factors.

Nutrition strategy

Built for care-management workflows: choose a case, apply structured targets, and escalate by clinical response.

Nutritional case selector

Adults with T2D and excess adiposity where glycemic control and weight reduction are dual goals.

Core targets

  • Carbohydrate pattern focused on quality and consistency (individualized, not one-size-fits-all).
  • Higher satiety meal structure (protein + fiber first) to reduce caloric drift.
  • Cardiometabolic risk reduction through sustainable eating pattern + activity pairing.

Implementation moves

  • Use plate model: non-starchy vegetables + lean protein anchor, then high-fiber carbs.
  • Default to water/zero-calorie beverages; avoid routine sugar-sweetened drinks.
  • Use one behavioral target every 2 weeks (e.g., late-night eating reduction).

Monitoring + escalation

  • Weight trend, A1c/CGM pattern (if available), blood pressure, adherence barriers.
  • Escalate if persistent hyperglycemia, progressive weight gain, or low satiety despite adherence.

Guideline anchors

  • ADA Standards of Care (current edition): nutrition therapy + weight management in diabetes.
  • AACE/ACE obesity guidance: chronic disease framework for obesity treatment.

Education-only guidance. Final plans must be individualized by licensed clinicians using patient-specific labs, comorbidities, and medication context.

AI pharmacist chat

Not medical advice

Rx Chat

Ready to translate today’s intel into bedside-friendly talking points. Ask about a drug, policy ripple, or operational scenario whenever you’re ready.

Always verify against patient-specific data.

Consult form

Direct to Derek

Education hub

Expanded clinical depth with guideline-anchored framing for diagnosis, treatment sequencing, monitoring, and escalation decisions.

Choose a guide

Full library

Draft · needs Derek review

What is inside

  • Guideline-based disease framing + diagnostic criteria checkpoints
  • First-line and add-on treatment pathways with clinical rationale
  • Monitoring cadence, target metrics, and escalation/de-escalation triggers
  • Safety red flags, contraindication reminders, and patient counseling pearls

Guideline domains referenced

  • ADA Standards of Care (diabetes, obesity, CKD risk integration)
  • ACC/AHA and ACC/AHA/HFSA guidance (hypertension, CAD, HF, atrial fibrillation)
  • KDIGO and KDOQI references (CKD staging, monitoring, renal-safe strategy)
  • GOLD and GINA reports (COPD/asthma control with inhaler optimization)
  • IDSA-aligned outpatient infection frameworks (sinusitis, CAP, cellulitis, UTI)
  • AACE/ACE and obesity-focused guidance (weight-centric pharmacotherapy context)

Inline citations are included in the playbooks to support nurse education and pharmacist review workflows.

Licensing

Enterprise-ready clinical content engine

This platform can be licensed to provider groups, digital health companies, payers, and pharmacy organizations that need medication intelligence + disease education in one product.

  • White-label disease playbooks for patient and provider education
  • Medication lookup with class/MOA, dosing, monitoring, and renal considerations
  • Interaction workflow designed for fast clinical triage and safer prescribing
  • Configurable deployment for private-clinic, enterprise, or payer environments

Commercial next steps

  1. Package this as per-seat + per-site licensing
  2. Add client-specific branding and formulary overlays
  3. Pilot with 1-2 practices and capture outcomes
  4. Publish a case study to support enterprise sales
Discuss Licensing